Conmed (CNMD) Change in Receivables (2010 - 2026)

Conmed has reported Change in Receivables for 17 years, with the latest figure at -$18.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 1.99% year-over-year to -$18.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 114.99% YoY), and the FY2025 full-year result was $2.4 million, up 45.83% from the prior year.
• Change in Receivables for Q1 2026 stood at -$18.6 million, down from $22.7 million in the prior quarter.
• The five-year high for Change in Receivables was $22.7 million in Q4 2025, with the low at -$19.0 million in Q1 2025.
• Historically, Change in Receivables has averaged $2.2 million across 5 years, with a median of $908000.0 in 2024.
• Annual changes were most pronounced in 2023 — Change in Receivables soared 12578.53% — and 2025, when it slumped 2190.75%.
• Conmed's Change in Receivables stood at -$10.9 million in 2022, then jumped by 183.14% to $9.1 million in 2023, then soared by 36.97% to $12.4 million in 2024, then jumped by 82.83% to $22.7 million in 2025, then tumbled by 182.07% to -$18.6 million in 2026.
• The last three Change in Receivables figures came in at -$18.6 million (Q1 2026), $22.7 million (Q4 2025), and -$9.2 million (Q3 2025), per Business Quant data.